Study of insulin resistance in cybrid cells harboring diabetes-susceptible and diabetes-protective mitochondrial haplogroups

Mitochondrion

Volumn 13, Issue 6, 2013, Pages 888-897

  Weng, Shao Wen ^a   Kuo, Hsiao Mei ^a   Chuang, Jiin Haur ^a   Lin, Tsu Kung ^a   Huang, Hui Lin ^a   Lin, Hung Yu ^a,b   Liou, Chia Wei ^a   Wang, Pei Wen ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Cybrid; Insulin resistance; Mitochondria; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; CELL NUCLEUS DNA; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL MEMBRANE; CHINESE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DIABETES MELLITUS; DISEASE PREDISPOSITION; DISEASE RESISTANCE; ENZYME PHOSPHORYLATION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HYBRID CELL; INSULIN RESISTANCE; JAPANESE; MITOCHONDRION; OSTEOSARCOMA CELL; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

CYBRID; INSULIN RESISTANCE; MITOCHONDRIA; OXIDATIVE STRESS;

BLOTTING, WESTERN; CELL LINE, TUMOR; DIABETES MELLITUS; FLOW CYTOMETRY; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 4; HAPLOTYPES; HUMANS; INSULIN RESISTANCE; MAP KINASE SIGNALING SYSTEM; PROTEIN TRANSPORT; REACTIVE OXYGEN SPECIES;

EID: 84887032270     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2013.08.001     Document Type: Article

References (46)

1. 2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J. Clin. Invest. 2009, 119:573-581.
2. Avruch J. Insulin signal transduction through protein kinase cascades. Mol. Cell. Biochem. 1998, 182:31-48.
3. Bloch-Damti A., Bashan N. Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid. Redox Signal. 2005, 7:1553-1567.
4. Bryant N.J., Govers R., James D.E. Regulated transport of the glucose transporter GLUT4. Nat. Rev. Mol. Cell Biol. 2002, 3:267-277.
5. Casteels K., Ong K., Phillips D., Bendall H., Pembrey M. Mitochondrial 16189 variant, thinness at birth, and type-2 diabetes. ALSPAC study team. Avon Longitudinal Study of Pregnancy and Childhood. Lancet 1999, 353:1499-1500.
6. Chinnery P.F., Elliott H.R., Syed A., Rothwell P.M. Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: a genetic association study. Lancet Neurol. 2010, 9:498-503.
7. Cifuentes M., Garcia M.A., Arrabal P.M., Martinez F., Yanez M.J., Jara N., Weil B., Dominguez D., Medina R.A., Nualart F. Insulin regulates GLUT1-mediated glucose transport in MG-63 human osteosarcoma cells. J. Cell. Physiol. 2011, 226:1425-1432.
8. Darvishi K., Sharma S., Bhat A.K., Rai E., Bamezai R.N. Mitochondrial DNA G10398A polymorphism imparts maternal haplogroup N a risk for breast and esophageal cancer. Cancer Lett. 2007, 249:249-255.
9. Feder J., Blech I., Ovadia O., Amar S., Wainstein J., Raz I., Dadon S., Arking D.E., Glaser B., Mishmar D. Differences in mtDNA haplogroup distribution among 3 Jewish populations alter susceptibility to T2DM complications. BMC Genomics 2008, 9:198.
10. Garvey W.T., Maianu L., Zhu J.H., Brechtel-Hook G., Wallace P., Baron A.D. Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J. Clin. Invest. 1998, 101:2377-2386.
11. Gennaro G., Menard C., Michaud S.E., Deblois D., Rivard A. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor. Circulation 2004, 110:3367-3371.
12. Gerbitz K.D., van den Ouweland J.M., Maassen J.A., Jaksch M. Mitochondrial diabetes mellitus: a review. Biochim. Biophys. Acta 1995, 1271:253-260.
13. Goldstein B.J., Mahadev K., Wu X. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes 2005, 54:311-321.
14. Heilbronn L.K., Gan S.K., Turner N., Campbell L.V., Chisholm D.J. Markers of mitochondrial biogenesis and metabolism are lower in overweight and obese insulin-resistant subjects. J. Clin. Endocrinol. Metab. 2007, 92:1467-1473.
15. Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
16. Kahn B.B. Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes. J. Clin. Invest. 1992, 89:1367-1374.
17. Lee H.Y., Choi C.S., Birkenfeld A.L., Alves T.C., Jornayvaz F.R., Jurczak M.J., Zhang D., Woo D.K., Shadel G.S., Ladiges W., Rabinovitch P.S., Santos J.H., Petersen K.F., Samuel V.T., Shulman G.I. Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. Cell Metab. 2010, 12:668-674.
18. Lin T.K., Lin H.Y., Chen S.D., Chuang Y.C., Chuang J.H., Wang P.W., Huang S.T., Tiao M.M., Chen J.B., Liou C.W. The creation of cybrids harboring mitochondrial haplogroups in the Taiwanese population of ethnic Chinese background: an extensive in vitro tool for the study of mitochondrial genomic variations. Oxid. Med. Cell. Longev. 2012, 2012:824275.
19. Liou C.W., Lin T.K., Huei Weng H., Lee C.F., Chen T.L., Wei Y.H., Chen S.D., Chuang Y.C., Weng S.W., Wang P.W. A common mitochondrial DNA variant and increased body mass index as associated factors for development of type 2 diabetes: additive effects of genetic and environmental factors. J. Clin. Endocrinol. Metab. 2007, 92:235-239.
20. Liou C.W., Lin T.K., Chen J.B., Tiao M.M., Weng S.W., Chen S.D., Chuang Y.C., Chuang J.H., Wang P.W. Association between a common mitochondrial DNA D-loop polycytosine variant and alteration of mitochondrial copy number in human peripheral blood cells. J. Med. Genet. 2010, 47:723-728.
21. Liou C.W., Chen J.B., Tiao M.M., Weng S.W., Huang T.L., Chuang J.H., Chen S.D., Chuang Y.C., Lee W.C., Lin T.K., Wang P.W. Mitochondrial DNA coding and control region variants as genetic risk factors for type 2 diabetes mellitus. Diabetes 2012, 61:2642-2651.
22. MacDougald O.A., Lane M.D. Transcriptional regulation of gene expression during adipocyte differentiation. Annu. Rev. Biochem. 1995, 64:345-373.
23. Maddux B.A., See W., Lawrence J.C., Goldfine A.L., Goldfine I.D., Evans J.L. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of alpha-lipoic acid. Diabetes 2001, 50:404-410.
24. Maor G., Karnieli E. The insulin-sensitive glucose transporter (GLUT4) is involved in early bone growth in control and diabetic mice, but is regulated through the insulin-like growth factor I receptor. Endocrinology 1999, 140:1841-1851.
25. Maor G., Vasiliver-Shamis G., Hazan-Brill R., Wertheimer E., Karnieli E. GLUT4 in murine bone growth: from uptake and translocation to proliferation and differentiation. Am. J. Physiol. Endocrinol. Metab. 2011, 300:E613-E623.
26. Muslin A.J. MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clin. Sci. (Lond.) 2008, 115:203-218.
27. Paglialunga S., van Bree B., Bosma M., Valdecantos M.P., Amengual-Cladera E., Jorgensen J.A., van Beurden D., den Hartog G.J., Ouwens D.M., Briede J.J., Schrauwen P., Hoeks J. Targeting of mitochondrial reactive oxygen species production does not avert lipid-induced insulin resistance in muscle tissue from mice. Diabetologia 2012, 55:2759-2768.
28. Petersen K.F., Dufour S., Befroy D., Garcia R., Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 2004, 350:664-671.
29. Phielix E., Schrauwen-Hinderling V.B., Mensink M., Lenaers E., Meex R., Hoeks J., Kooi M.E., Moonen-Kornips E., Sels J.P., Hesselink M.K., Schrauwen P. Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients. Diabetes 2008, 57:2943-2949.
30. Poulton J., Brown M.S., Cooper A., Marchington D.R., Phillips D.I. A common mitochondrial DNA variant is associated with insulin resistance in adult life. Diabetologia 1998, 41:54-58.
31. Poulton J., Luan J., Macaulay V., Hennings S., Mitchell J., Wareham N.J. Type 2 diabetes is associated with a common mitochondrial variant: evidence from a population-based case-control study. Hum. Mol. Genet. 2002, 11:1581-1583.
32. Pyle A., Foltynie T., Tiangyou W., Lambert C., Keers S.M., Allcock L.M., Davison J., Lewis S.J., Perry R.H., Barker R., Burn D.J., Chinnery P.F. Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann. Neurol. 2005, 57:564-567.
33. Rahaman S.O., Lennon D.J., Febbraio M., Podrez E.A., Hazen S.L., Silverstein R.L. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab. 2006, 4:211-221.
34. 2, a necessary evil for cell signaling. Science 2006, 312:1882-1883.
35. Rose G., Passarino G., Carrieri G., Altomare K., Greco V., Bertolini S., Bonafe M., Franceschi C., De Benedictis G. Paradoxes in longevity: sequence analysis of mtDNA haplogroup J in centenarians. Eur. J. Hum. Genet. 2001, 9:701-707.
36. Ruiz-Pesini E., Lapena A.C., Diez-Sanchez C., Perez-Martos A., Montoya J., Alvarez E., Diaz M., Urries A., Montoro L., Lopez-Perez M.J., Enriquez J.A. Human mtDNA haplogroups associated with high or reduced spermatozoa motility. Am. J. Hum. Genet. 2000, 67:682-696.
37. Ryder J.W., Yang J., Galuska D., Rincon J., Bjornholm M., Krook A., Lund S., Pedersen O., Wallberg-Henriksson H., Zierath J.R., Holman G.D. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes 2000, 49:647-654.
38. Samani A.A., Yakar S., LeRoith D., Brodt P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr. Rev. 2007, 28:20-47.
39. Santoro A., Salvioli S., Raule N., Capri M., Sevini F., Valensin S., Monti D., Bellizzi D., Passarino G., Rose G., De Benedictis G., Franceschi C. Mitochondrial DNA involvement in human longevity. Biochim. Biophys. Acta 2006, 1757:1388-1399.
40. Schrauwen-Hinderling V.B., Kooi M.E., Hesselink M.K., Jeneson J.A., Backes W.H., van Echteld C.J., van Engelshoven J.M., Mensink M., Schrauwen P. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 2007, 50:113-120.
41. Shi H., Huang Y., Zhou H., Song X., Yuan S., Fu Y., Luo Y. Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin. Blood 2007, 110:2899-2906.
42. Wang Q., Somwar R., Bilan P.J., Liu Z., Jin J., Woodgett J.R., Klip A. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol. Cell. Biol. 1999, 19:4008-4018.
43. Yasukawa T., Yang M.Y., Jacobs H.T., Holt I.J. A bidirectional origin of replication maps to the major noncoding region of human mitochondrial DNA. Mol. Cell 2005, 18:651-662.
44. Yin W., Park J.I., Loeser R.F. Oxidative stress inhibits insulin-like growth factor-I induction of chondrocyte proteoglycan synthesis through differential regulation of phosphatidylinositol 3-Kinase-Akt and MEK-ERK MAPK signaling pathways. J. Biol. Chem. 2009, 284:31972-31981.
45. Zhao M., Liu Y., Wang X., New L., Han J., Brunk U.T. Activation of the p38 MAP kinase pathway is required for foam cell formation from macrophages exposed to oxidized LDL. APMIS 2002, 110:458-468.
46. Zierath J.R., He L., Guma A., Odegoard Wahlstrom E., Klip A., Wallberg-Henriksson H. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 1996, 39:1180-1189.